Menu Search
Equities

Cambridge Nutritional Sciences PLC

RVKA:DEU

Cambridge Nutritional Sciences PLC

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cambridge Nutritional Sciences plc is a United Kingdom-based diagnostics testing company. The principal activities of the Company are the manufacture, development and distribution of medical diagnostics products for the food sensitivity testing market. The Company’s segments include Health and Nutrition, and Corporate. The Health and Nutrition division specializes in the research, development and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis for the general public, clinics and health professionals as well as supplying the point-of-care Food Detective test. Its range of food sensitivity and functional health tests can help identify the root cause of gut health issues. Its brands include FoodPrint, Food Detective, CNSLab, and My Health Tracker. The Company has a global customer base across more than 75 countries, and its products are used by more than 170 laboratories worldwide.

  • Revenue in GBP (TTM)9.77m
  • Net income in GBP-328.00k
  • Incorporated2004
  • Employees94.00
  • Location
    Cambridge Nutritional Sciences PLCEden Research ParkHenry Crabb Road, LittleportELY CB6 1SEUnited KingdomGBR
  • Phone+44 135 386 2220
  • Fax+44 125 976 1853
  • Websitehttps://www.omegadx.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.